Thermo Fisher Scientific | TMO - Ebit

Stock Price
468.04
Daily Change
-1.67 -0.36%
Monthly
-2.50%
Yearly
11.08%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $1.91B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
Agilent USD 353M 90M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD -418.8M 845.4M Sep/2025
Boston Scientific USD 1.05B 190M Mar/2026
Bruker USD 76.3M 7.6M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 538M 26M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
General Electric Aerospace USD 2.09B 416M Mar/2026
Henry Schein USD 186M 12M Dec/2025
Illumina USD 256M 6M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 11M Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Olympus JPY 28B 5.56B Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Repligen USD 19.97M 3.16M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Veracyte USD 24.63M 1.52M Dec/2025
Waters USD 270.52M 78.4M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025